In-house members
10
Total footprint
15,000 sq ft
The incubator where it all started, our St Philips incubator is typically home to earlier-stage Deep Tech teams of around 10-20 and has been the launchpad for many success stories — from startups scaling to bigger facilities to game-changing company exits.
Work alongside pioneering startups tackling global issues — from next-generation battery materials and better diabetes treatments to quantum-enabled cameras that track greenhouse gas leaks.
Our St Philips incubator (previously Unit DX) opened in 2017 to improve access to lab space and facilities for scientific companies in Bristol.
Just a 10-minute walk from Bristol Temple Meads train station, the space combines purpose-built laboratories, flexible offices and cutting-edge instrumentation.
Rent an entire lab or just a lab bench; have a private office or share one — and access our platform of support, providing opportunities to attend workshops and events, connect with other founders, and find a mentor.
Get in touch if you are after shared or private lab space at St Philips or browse our other sites for more private lab space.
Travel between locations is measured in walking distance
Albert Rd
0.5 miles / 11 min
0.7 miles / 15 min
Reach Industries is optimising lab and scientist efficiency with its Lumi™ visual intelligence platform. By automating data capture and analysis for experiments, observations and complex scientific workflows, the platform functions as a streamlined operating system that is accelerating R&D, improving compliance and increasing reproducibility.
Argonaute RNA is developing safe, reliable and targeted methods of temporarily silencing genes in different tissue cells. It does this via the proprietary modification of small interfering RNA (siRNA), using a novel stabilisation method to overcome previous obstacles to developing siRNA drugs for healthcare.
neo-fossil is developing new technology using cell engineering to help reverse the threat of climate change. By optimising biology, it is creating new fossils that harvest atmospheric carbon dioxide, storing it for centuries.
Anaphite is decarbonising battery production by accelerating the electric vehicle (EV) industry’s shift to dry battery electrode coating. Its technology platform solves the challenges of dry mixing and manufactures film-forming dry powders called Dry Coating Precursor (DCP®). This process enables cell manufacturers to reduce their energy use by up to 30% and create better, more sustainable batteries at lower cost.
Lifecare is committed to improving the lives of people and pets with diabetes. It is developing the next-generation of miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers to the market. The company’s spin-off entity Lifecare Chemistry Ltd was founded to enhance research collaboration and secure ownership of its improved analyte-specific chemical receptor developments.
Fine Agrochemicals is enhancing crop quality for fruit and flower growers in agricultural, ornamental and landscape markets using its plant growth regulator (PGR) technology. Its PGR products, made using naturally occurring molecules through fermentation and combined with chemically synthesised compounds, help stimulate plant cells to enhance nutrient levels and targeted growth for improved crop outputs.
Celltris is reimagining battery cell design to unlock fast charging for heavy electric vehicles. Its mechanical approach to cell terminal design enables battery packs to be built at a 40% reduction in component costs with a 60% cut in heat generation. This enables industrial vehicles to be charged 2-3x faster without the thermal penalty, removing the need for oversized cooling systems or bottlenecks from slow charge times.
Folium Science is increasing agricultural productivity by enhancing animal welfare and feed efficiency in livestock farming while reducing environmental impact. Its unique CRISPR-Cas technology platform harnesses natural biological systems to safely modulate animal microbiomes by regulating metabolic functions and targeting unwanted bacteria with extreme precision. This approach helps reduce reliance on antibiotics and can be applied to both plants and soil to improve their bacterial biomes for optimal growing conditions.
Dimension Biotechnologies is addressing unmet global vascular health challenges by improving diagnostic tools. Its transformative technology non-invasively monitors microscopic blood vessels at the biochemical level enabling doctors, drug developers and scientists to rapidly assess microvascular health and disease.
.webp)